SMOK-study: selective serotonin reuptake inhibitor medication in pregnant women - effect on development of childre
Completed
- Conditions
- SSRI (selective serotonin reuptake inhibitor), pregnancyPregnancy and ChildbirthAntidepressant use in pregnancy
- Registration Number
- ISRCTN53506435
- Lead Sponsor
- niversity Medical Centre Groningen (UMCG) (The Netherlands)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 120
Inclusion Criteria
Newborn child exposed to an SSRI in utero
Exclusion Criteria
1. Newborn child exposed to a non-SSRI antidepressant in utero
2. Newborn child exposed to anti-epileptic drugs in utero
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. In the first week after birth and at three months post-term: quality of general movements<br>2. At the age of 2 years and 6 years: motor and cognitive development
- Secondary Outcome Measures
Name Time Method o secondary outcome measures